Daily Digest
Cardano's proposal to tokenize ₳22M in RWAs is active, ending in 3 days, while Injective seeks to adjust hourly funding rate caps for RWA perpetuals, closing in 2 days. CoW Protocol's affiliate program extension (CIP-93) is live but ends today, requiring urgent DAO attention.
Protocols in this digest
Items
15
Protocols
7
Closing soon
3
Next 3 days
Alpha takeaways
Real-world asset (RWA) tokenization and institutional adoption are driving governance priorities across protocols, with treasury allocations and risk management updates taking center stage.
This governance cycle highlights a strong focus on RWA tokenization, particularly in Cardano and Injective, where significant treasury funds are being allocated to acquire and tokenize physical assets like copper and enhance institutional-grade financial products. Concurrently, protocols like Morpho and Injective are refining risk parameters and upgrading infrastructure to support these initiatives, signaling a broader trend toward institutional adoption and market expansion. However, coordination risks emerge as protocols navigate complex treasury withdrawals, parameter changes, and upgrades, requiring careful oversight to ensure alignment with long-term strategic goals.
Highlights
Closing in 3 days - Category: treasury
Closing in 2 days - Category: treasury
All items
Enable 11 new LLTVs on Morpho Midnight, which takes the set from 8 to 19 values. Morpho Blue is not affected. Full set and new values available in the discussion linked below.
Stay ahead
Weekly highlights, deadlines, and status changes for your watchlist — no account required.
Closing in 1 day - Category: parameter_change
The Veyra Mainnet Upgrade marks a major advancement in Injective's mission to bring global financial markets onchain. Building on the recent launch of Injective Institutional Rail, Veyra introduces a comprehensive suite of new capabilities designed to accelerate institutional adoption, expand real world asset (RWA) markets, and enable the next generation of tokenized financial products. As Injective prepares for a new wave of institutional RWA launches, Veyra strengthens the underlying...